Kuur Therapeutics
About:
Kuur Therapeutics is committed to transforming the lives of patients with cancer & is leading the development cell therapies.
Website: https://kuurtx.com/
Twitter/X: CellMedica
Top Investors: Invesco, Wellcome Trust, Salica, Imperial Innovations, Woodford Investment Management
Description:
Kuur Therapeutics is committed to transforming the lives of patients with cancer and is leading the development of off-the-shelf engineered CAR-NKT cell therapies. Our approach combines the highly differentiated, natural biology of a specific subset of cytotoxic T cells, called natural killer T cells (NKT cells) and innovative CAR construct engineering. In combination, this delivers a very compelling and unique platform, that we believe has the potential to produce many future therapies targeting both hematological and solid tumors.
$192M
$1M to $10M
London, England, United Kingdom
2005-01-01
info(AT)kuurtx.com
Gregg Sando
51-100
2021-01-18
Private
© 2025 bioDAO.ai